Demonstrates improved proteolytic stability in macrocyclic peptides, highlighting a new peptide assembly technology.
-amines, tolerating all other nucleophilic side chains, including cysteine, across a broad range of peptide sequences and linker spacings. The resulting macrocycles support stepwise bicyclization and modular postcyclization conjugation with nucleic acids, small-molecule drugs, and affinity tags. Application to antimicrobial peptides demonstrates enhanced conformational constraint and markedly improved proteolytic stability. Importantly, the chemistry is intrinsically compatible with solid-phase peptide synthesis and fully integrated, end-to-end automated workflows without hardware modification. This PMDA-mediated stapling strategy establishes a versatile, automation-ready linker platform for rapid assembly and functional diversification of macrocyclic peptides.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: